Exelixis News
Most Popular Exelixis Story
Exelixis chops 270 jobs in restructuring
South San Francisco-based Exelixis is axing 270 jobs--40 percent of its workforce--as it circles its wagons around its top three cancer programs. Citing SEC documents, the San Francisco Business... Read more...
Latest Headlines
- March 9, 2010
- May 28, 2009
- December 12, 2008
- November 24, 2008
- November 10, 2008
- October 23, 2008
- July 23, 2008
- June 27, 2008
- November 9, 2007
- October 16, 2007
- October 4, 2007
- September 21, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
